CMS Innovation Center and FDA introduce ACCESS and TEMPO models to integrate digital health devices into Medicare, boosting care and payment innovation for chronic conditions.

FDA and CMS launch pilots to expand Medicare access to digital health technologies through outcome-aligned payments and regulatory flexibility, targeting chronic disease management.

Explore the complex regulatory landscape governing data exchange in value-based care, including CMS rules, HIPAA, and operational challenges affecting healthcare compliance and data governance.

CMS releases preliminary guidance for states to implement Medicaid community engagement requirements by 2027, detailing eligibility, exemptions, verification, and compliance procedures.

CMS introduces the WISeR Model in six states to optimize prior authorization using AI, aiming to reduce low-value services and Medicare costs starting 2026.

The GAO report uncovers ongoing unauthorized plan changes and enrollment fraud within the ACA marketplace, exposing verification weaknesses and highlighting the need for stronger consumer and regulatory protections.

CMS finalizes the mandatory Ambulatory Specialty Model in Medicare, expanding value-based care to specialists treating chronic conditions with two-sided financial risk and collaborative care requirements.

CMS initiates the WISeR Model in six states to employ AI-driven prior authorization, targeting reduced low-value services and Medicare spending under traditional fee-for-service programs.

Clear wins CMS contract to implement Clear1 biometric identity platform for Medicare.gov, enhancing secure, seamless access for Medicare beneficiaries.

CMS proposes expanded 2027 Medicare Advantage benefits to include FDA-approved hemp products as supplemental coverage for chronically ill enrollees, following federal and state hemp regulations.